These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29065740)

  • 21. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic assessment of an anti-HCV screening program in Italy.
    Ruggeri M; Coretti S; Gasbarrini A; Cicchetti A
    Value Health; 2013; 16(6):965-72. PubMed ID: 24041346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany.
    Schaufler TM; Wolff M
    Appl Health Econ Health Policy; 2010; 8(3):191-202. PubMed ID: 20408603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A paradigm shift in the outpatient approach to liver function tests.
    Senadhi V
    South Med J; 2011 Jul; 104(7):521-5. PubMed ID: 21886053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus screening before adjuvant chemotherapy in patients with early-stage breast cancer: a cost-effectiveness analysis.
    Wong WW; Hicks LK; Tu HA; Pritchard KI; Krahn MD; Feld JJ; Chan KK
    Breast Cancer Res Treat; 2015 Jun; 151(3):639-52. PubMed ID: 25962692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized treatment of HBeAg-negative chronic hepatitis B using pegylated interferon-α2a as first-line and week-12 HBV DNA/HBsAg stopping rule: a cost-effectiveness analysis.
    Iannazzo S; Coco B; Brunetto MR; Rossetti F; Caputo A; Latour A; Espinos B; Bonino F
    Antivir Ther; 2013; 18(4):623-33. PubMed ID: 23486701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: Comparing ultrasonography with two-stage screening.
    Kuo MJ; Chen HH; Chen CL; Fann JC; Chen SL; Chiu SY; Lin YM; Liao CS; Chang HC; Lin YS; Yen AM
    World J Gastroenterol; 2016 Mar; 22(12):3460-70. PubMed ID: 27022228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cost of screening for hepatocarcinoma in patients with cirrhosis: a prospective study].
    Sort P; Alvarez MA; Bargalló A; Isava A; Muñoz M; Porta F; Rodríguez E; Vida F
    Gastroenterol Hepatol; 2011 Oct; 34(8):519-23. PubMed ID: 21703723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cost-effectiveness of alternative strategies against HBV in Italy.
    Ruggeri M; Cicchetti A; Gasbarrini A
    Health Policy; 2011 Sep; 102(1):72-80. PubMed ID: 21035229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
    Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
    J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation.
    Larcos G; Sorokopud H; Berry G; Farrell GC
    AJR Am J Roentgenol; 1998 Aug; 171(2):433-5. PubMed ID: 9694470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon treatment for chronic hepatitis B or C infection: costs and effectiveness.
    Wong JB
    Acta Gastroenterol Belg; 1998; 61(2):238-42. PubMed ID: 9658620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease burden of chronic hepatitis C among immigrants in Canada.
    Chen W; Krahn M
    J Viral Hepat; 2015 Dec; 22(12):1043-54. PubMed ID: 26110922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Budget Impact Analysis of Against Colorectal Cancer In Our Neighborhoods (ACCION): A Successful Community-Based Colorectal Cancer Screening Program for a Medically Underserved Minority Population.
    Kim B; Lairson DR; Chung TH; Kim J; Shokar NK
    Value Health; 2017 Jun; 20(6):809-818. PubMed ID: 28577699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The costs and benefits of enhanced depression care to employers.
    Wang PS; Patrick A; Avorn J; Azocar F; Ludman E; McCulloch J; Simon G; Kessler R
    Arch Gen Psychiatry; 2006 Dec; 63(12):1345-53. PubMed ID: 17146009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.
    Arnold DT; Bentham LM; Jacob RP; Lilford RJ; Girling AJ
    BMC Fam Pract; 2011 Mar; 12():9. PubMed ID: 21371303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
    Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
    Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
    Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
    Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.